• 1. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148
• 2. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 3. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
• 4. An amphoteric reactivity of a mixed-valent bis(μ-oxo)dimanganese(iii,iv) complex acting as an electrophile and a nucleophile?
  Muniyandi Sankaralingam,So Hyun Jeon,Yong-Min Lee,Mi Sook Seo,Wonwoo Nam Dalton Trans., 2016,45, 376-383
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

Introduction to 2-Amino-4-(Morpholine-4-Sulfonyl)Phenol (CAS No. 90874-23-0)

2-Amino-4-(Morpholine-4-sulfonyl)phenol (CAS No. 90874-23-0) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, also known as Morpholine-4-sulfonyl-2-amino-phenol, is characterized by its unique structural features, which include an amino group, a morpholine sulfonyl group, and a phenolic hydroxyl group. These functional groups endow the molecule with a range of biological activities and potential therapeutic applications.

The chemical structure of 2-Amino-4-(Morpholine-4-sulfonyl)phenol can be represented as C₁₁H₁₅N₃O₄S, with a molecular weight of 269.31 g/mol. The compound is typically synthesized through a series of well-defined chemical reactions, including the reaction of 2-amino-4-nitrophenol with morpholine sulfonyl chloride followed by reduction of the nitro group to an amino group. This synthetic route ensures high purity and yield, making it suitable for various research and development purposes.

In recent years, 2-Amino-4-(Morpholine-4-sulfonyl)phenol has been extensively studied for its potential as a lead compound in drug discovery. One of the key areas of interest is its role as an inhibitor of specific enzymes involved in various disease pathways. For instance, research has shown that this compound exhibits potent inhibitory activity against tyrosinase, an enzyme responsible for melanin production in the skin. This property makes it a promising candidate for the development of skin whitening agents and treatments for hyperpigmentation disorders.

Beyond its potential in dermatological applications, 2-Amino-4-(Morpholine-4-sulfonyl)phenol has also been explored for its anti-inflammatory and antioxidant properties. Studies have demonstrated that it can effectively reduce inflammation by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. Additionally, its antioxidant activity helps to neutralize free radicals, thereby protecting cells from oxidative damage. These findings suggest that the compound could be beneficial in the treatment of inflammatory diseases and conditions associated with oxidative stress.

The pharmacokinetic properties of 2-Amino-4-(Morpholine-4-sulfonyl)phenol have also been investigated to assess its suitability as a therapeutic agent. Preclinical studies have shown that it exhibits good oral bioavailability and favorable pharmacokinetic profiles, making it suitable for further development into drug formulations. Moreover, the compound has demonstrated low toxicity in animal models, which is a crucial factor in drug safety and efficacy.

In the realm of cancer research, 2-Amino-4-(Morpholine-4-sulfonyl)phenol has shown promise as a potential anticancer agent. It has been found to induce apoptosis in various cancer cell lines by modulating key signaling pathways involved in cell survival and proliferation. Specifically, it can inhibit the activation of Akt and ERK signaling pathways, which are often dysregulated in cancer cells. These findings highlight its potential as a novel therapeutic agent for cancer treatment.

The structural versatility of 2-Amino-4-(Morpholine-4-sulfonyl)phenol also makes it an attractive scaffold for medicinal chemistry optimization. Researchers have synthesized numerous derivatives by modifying the functional groups attached to the core structure. These modifications aim to enhance the compound's potency, selectivity, and pharmacokinetic properties while reducing potential side effects. Some notable derivatives include those with substituted aromatic rings or additional functional groups that improve solubility and metabolic stability.

In conclusion, 2-Amino-4-(Morpholine-4-sulfonyl)phenol (CAS No. 90874-23-0) is a multifaceted compound with significant potential in various therapeutic areas. Its unique chemical structure and biological activities make it a valuable candidate for further research and development in medicinal chemistry and pharmaceutical sciences. As ongoing studies continue to uncover new insights into its mechanisms of action and therapeutic applications, this compound is poised to play a crucial role in advancing our understanding and treatment of various diseases.

• 22184-97-0(3-(morpholine-4-sulfonyl)aniline)
• 21626-70-0(4-(morpholine-4-sulfonyl)aniline)
• 56807-17-1(2-methoxy-5-(morpholine-4-sulfonyl)aniline)
• 208643-03-2(2-(Morpholinosulfonyl)aniline)
• 554407-02-2(4-methoxy-3-(morpholine-4-sulfonyl)aniline)
• 112195-27-4(Methyl 2-amino-1-(3-amino-4-hydroxyphenyl)-2-oxoethanesulfonate hydrochloride)
• 735322-12-0(2-(4-ETHOXY-PHENOXY)-5-(MORPHOLINE-4-SULFONYL)-PHENYLAMINE)
• 656804-36-3(Morpholine, 4-[(3,4-dihydroxyphenyl)sulfonyl]-)
• 6837-92-9(3-Amino-N,N-diethyl-4-hydroxybenzene-1-sulfonamide)
• 3077-65-4(4-(morpholine-4-sulfonyl)phenol)